Anarchic Deposits: The Intersection of Calciphylaxis and Hemochromatosis, A Case Report
DOI:
https://doi.org/10.17140/IMOJ-1-105Abstract
Calciphylaxis is a rare disease occurring in usually obese women around the age of 40 years subject to hemodialysis. It can be prevented by controlling drug intake and biological markers. However, when installed it is irreversible and lethal. We report the case of a very young woman victim of non-observation with very deleterious consequence of calciphylaxis
References
Hafner J, Keusch G, Wahl C, Burg G. Calciphylaxis: A syn-drome of skin necrosis and acral gangrene in chronic renal fail-ure. Vasa. 1998; 27: 137-143. Web site. http://europepmc.org/ abstract/med/9747147. Accessed March 18, 2017.
Rubinger D, Friedlaender MM, Silver J, Kopolovic Y, Czacz-kes WJ, Popovtzer MM. Progressive vascular calcification with necrosis of extremities in hemodialysis patients: A possible role of iron overload. Am J Kidney Dis. 1986; 7(2): 125-129. doi: 10.1016/S0272-6386(86)80132-9
Vassa N, Twardowski ZJ, Campbell J. Hyperbaric oxygen-therapy in calciphylaxis-induced skin necrosis in a peritone-aldialysis patient. Am J Kidney Dis. 1994; 23: 878-881. doi: 10.1016/S0272-6386(12)80145-4
Guerra G, Shah RC, Ross EA. Rapid resolution of calciphy-laxis with intravenous sodium thiosulfate andcontinuous veno-venous haemofiltration using low calcium replacement fluid: Case report. Nephrol Dial Transplant. 2005; 20: 1260-1262. doi: 10.1093/ndt/gfh825
Fine A, Zacharias J. Calciphylaxis is usually non-ulcerating: Risk factors, outcome and therapy. Kidney Int. 2002; 61: 2210- 2217. doi: 10.1046/j.1523-1755.2002.00375.x
Monney P, Nguyen QV, Perroud H, Descombes E. Rapid im-provement of calciphylaxis after intravenous pamidrona tether-apy in a patient with chronic renal failure. Nephrol Dial Trans-plant. 2004; 19: 2130-2132. doi: 10.1093/ndt/gfh305
Velasco N, MacGregor MS, Innes A, MacKay IG. Successful treatment of calciphylaxis with cinacalcet-an alternative to para-thyroidectomy? Nephrol Dial Transplant. 2006; 21: 1999-2004. doi: 10.1093/ndt/gfl114
Chen CH, Shu KH, Yang Y. Long-term effects of an oral iron chelator, deferasirox, in hemodialysis patients with iron overload. Hematology. 2015; 20(5): 304-310. doi: 10.1179/1607845414Y.0000000199
Guldbakke KK, Khachemoune A. Calciphylaxis. Int J Derma-tol. 2007; 46: 231-238. doi: 10.1111/j.1365-4632.2007.03160.x
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Internal Medicine (IMOJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.